|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Option (right to buy) | $ 43.1 | 02/03/2011 | M(1) | 5,000 | 01/01/2006(3) | 08/24/2014 | Class A Common Stock | 5,000 | (7) | 0 (6) | D | ||||
Option (right to buy) | $ 39.56 | 02/03/2011 | M(1) | 25,000 | 01/01/2008(4) | 09/20/2016 | Class A Common Stock | 25,000 | (7) | 0 (6) | D | ||||
Option (right to buy) | $ 35 | 02/03/2011 | M(1) | 20,000 | 01/01/2007(5) | 09/26/2015 | Class A Common Stock | 20,000 | (7) | 5,000 (6) | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
GEDEON HARVEY THE ESTEE LAUDER COMPANIES INC. 767 FIFTH AVENUE NEW YORK, NY 10153 |
EVP for Global Research & Dev. |
Harvey Gedeon, by Spencer G. Smul, attorney-in-fact | 02/07/2011 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The exercise of stock options and the sale of the underlying shares of Class A Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 9, 2010. |
(2) | The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. |
(3) | Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 16,666 shares exercisable from and after January 1, 2006, 16,666 shares exercisable from and after January 1, 2007 and 16,667 shares exercisable from and after January 1, 2008. |
(4) | Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 8,333 shares exercisable from and after January 1, 2008; 8,333 shares exercisable from and after January 1, 2009; 8,334 shares exercisable from and after January 1, 2010. |
(5) | Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 8,333 shares exercisable from and after January 1, 2007; 8,333 shares exercisable from and after January 1, 2008; 8,334 shares exercisable from and after January 1, 2009. |
(6) | The Reporting Person also has options to purchase at various prices 123,307 shares of Class A Common Stock, 56,666 of which are currently exercisable. |
(7) | Not Applicable |
(8) | Sales prices range from $87.05 to $88.03 per share, inclusive. |
(9) | Sales prices range from $88.11 to $88.35 per share, inclusive. |
(10) | Sales prices range from $90.00 to $90.99 per share, inclusive. |
(11) | Sales prices range from $91.00 to $91.30 per share, inclusive. |